盘点医药业一年新政:中医法实施 临床药加快审批

2017-11-11 医药界 新京报

用8个关键事件,梳理出一年来健康领域的新规新政以及公众关注的热点。

医事要闻一年新政 驱动健康新发展

这一年,医药行业新政频频出台,公立医院综合改革、中医药发展传承、互联网远程医疗等给百姓带来实惠;

这一年,国民营养计划发布,提出要以人民健康为中心,关注国民生命全周期、健康全过程的营养健康;

这一年,十九大报告提出“人民健康是民族昌盛和国家富强的重要标志”,把健康中国战略升级……

新京报健康周刊用8个关键事件,梳理出一年来健康领域的新规新政以及公众关注的热点。

信息化远程医疗将实现

根据国务院关于印发《“十三五”国家信息化规划》的通知,到2018年,信息技术促进医疗健康服务便捷化程度大幅提升,远程医疗服务体系基本形成;到2020年,基于感知技术和产品的新型健康信息服务逐渐普及,信息化对实现人人享有基本医疗卫生服务发挥显着作用。

医药分开综合改革实施

4月8日起,《北京市医药分开综合改革实施方案》正式实施。北京所有公立医疗机构取消挂号费、诊疗费,取消药品加成,设立医事服务费。半年来,全市参与改革的3700多家医疗机构半年来共完成门急诊量1亿多人次,城区部分社区卫生服务机构诊疗量增加20%以上。

中药注射剂使用受限制

中药注射剂不良反应问题严重,人力资源社会保障部关于印发国家基本医疗保险、工伤保险和生育保险药品目录(2017年版)的通知出炉,包括双黄连、清开灵、喜炎平、鱼腥草等在内的26种中药注射剂被明确限定为只能在二级及以上医疗机构使用。

36种谈判药品纳入医保

36种谈判药品纳入《国家基本医疗保险、工伤保险和生育保险药品目录(2017年版)》(以下简称药品目录)乙类范围,平均降价幅度达到44%,最高达到70%。其中包括31个西药和5个中成药。西药中有15种是肿瘤治疗药,覆盖了胃癌乳腺癌肺癌等癌种,中成药中有3个是肿瘤药。

首部中医药法7月实施

中国首部中医药法——《中华人民共和国中医药法》7月1日起实施。中医药法明确了中医药事业的重要地位和发展方针,提出建立符合中医药特点的管理制度,加大对中医药事业的扶持力度,坚持扶持与规范并重,加强对中医药的监管,同时加大对中医药违法行为的处罚力度。

国民营养计划确定目标

《国民营养计划(2017-2030年)》6月发布,制定了6个总目标。到2030年,营养法规标准体系将更加健全,营养工作体系更加完善,食物营养健康产业持续健康发展,传统食养服务更加丰富,“互联网+营养健康”的智能化应用普遍推广,居民营养健康素养进一步提高,营养健康状况显着改善。

临床急需药品加快审批

10月8日,中共中央办公厅、国务院办公厅发布《关于深化审评审批制度改革鼓励药品医疗器械创新的意见》,涉及加快临床急需药品和医疗器械的上市审评速度,解决公众用药需求。其中,中药注射剂再评价、鼓励罕见病药品研发、攻克国内外新药中国上市“延迟”等问题成为业内关注的焦点。

“健康中国”战略升级

在刚刚结束的十九大上,习近平总书记在报告中讲道:“人民健康是民族昌盛和国家富强的重要标志。要完善国民健康政策,为人民群众提供全方位全周期健康服务。”这意味着,“健康中国”从2016年的全国卫生与健康大会上的“优先发展战略地位”,已经成为党中央和各级政府为人民提供全方位全周期健康服务的理念。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1409170, encodeId=e08614091e0db, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Nov 13 06:02:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260646, encodeId=7ca7260646b0, content=不错的文章值得推荐!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Nov 12 00:25:37 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260645, encodeId=5a3c2606454d, content=不错的文章值得推荐!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Nov 12 00:25:32 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260618, encodeId=3fcd260618ea, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sat Nov 11 23:14:15 CST 2017, time=2017-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260560, encodeId=b95f26056045, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat Nov 11 18:55:33 CST 2017, time=2017-11-11, status=1, ipAttribution=)]
    2017-11-13 cathymary
  2. [GetPortalCommentsPageByObjectIdResponse(id=1409170, encodeId=e08614091e0db, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Nov 13 06:02:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260646, encodeId=7ca7260646b0, content=不错的文章值得推荐!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Nov 12 00:25:37 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260645, encodeId=5a3c2606454d, content=不错的文章值得推荐!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Nov 12 00:25:32 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260618, encodeId=3fcd260618ea, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sat Nov 11 23:14:15 CST 2017, time=2017-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260560, encodeId=b95f26056045, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat Nov 11 18:55:33 CST 2017, time=2017-11-11, status=1, ipAttribution=)]
    2017-11-12 明天会更好!

    不错的文章值得推荐!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1409170, encodeId=e08614091e0db, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Nov 13 06:02:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260646, encodeId=7ca7260646b0, content=不错的文章值得推荐!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Nov 12 00:25:37 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260645, encodeId=5a3c2606454d, content=不错的文章值得推荐!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Nov 12 00:25:32 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260618, encodeId=3fcd260618ea, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sat Nov 11 23:14:15 CST 2017, time=2017-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260560, encodeId=b95f26056045, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat Nov 11 18:55:33 CST 2017, time=2017-11-11, status=1, ipAttribution=)]
    2017-11-12 明天会更好!

    不错的文章值得推荐!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1409170, encodeId=e08614091e0db, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Nov 13 06:02:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260646, encodeId=7ca7260646b0, content=不错的文章值得推荐!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Nov 12 00:25:37 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260645, encodeId=5a3c2606454d, content=不错的文章值得推荐!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Nov 12 00:25:32 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260618, encodeId=3fcd260618ea, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sat Nov 11 23:14:15 CST 2017, time=2017-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260560, encodeId=b95f26056045, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat Nov 11 18:55:33 CST 2017, time=2017-11-11, status=1, ipAttribution=)]
    2017-11-11 thlabcde

    好资料学习了!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1409170, encodeId=e08614091e0db, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Nov 13 06:02:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260646, encodeId=7ca7260646b0, content=不错的文章值得推荐!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Nov 12 00:25:37 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260645, encodeId=5a3c2606454d, content=不错的文章值得推荐!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Nov 12 00:25:32 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260618, encodeId=3fcd260618ea, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sat Nov 11 23:14:15 CST 2017, time=2017-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260560, encodeId=b95f26056045, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat Nov 11 18:55:33 CST 2017, time=2017-11-11, status=1, ipAttribution=)]
    2017-11-11 131****1460

    学习了受益匪浅

    0

相关资讯

给不给医生讲课费 药企小心越线

“贿赂”的界定越是具体与明确,整治医药领域的商业贿赂行为则越为深入。

食药监总局加强互联网药品医疗器械监管,强化投诉举报处理

总局办公厅关于加强互联网药品医疗器械交易监管工作的通知食药监办法〔2017〕144号2017年11月02日 发布各省、自治区、直辖市食品药品监督管理局,新疆生产建设兵团食品药品监督管理局:为贯彻落实《国务院关于取消一批行政许可事项的决定》(国发〔2017〕46号)的要求,做好相关事中事后监管措施的衔接工作,现就加强互联网药品、医疗器械交易监管工作有关事项通知如下:一、落实监管责任。建立完善互联网药

京东入局,医药配送大战即将爆发

医药物流,京东来了!京东“闪电”配送,杀入医药物流9 月 26 日,京东物流的“医药云仓”在山东济南落地,这是京东 2017 年规划全国 11 个“医药云仓”中的第一个。京东物流负责人讲,要让医药行业,感受到京东的“闪电”配送!据了解,截止 2017 年 6 月,京东物流已经覆盖全国 2691 个区县,自营配送覆盖了 99% 的人口。52% 的订单 6 小时送达,92% 的订单当日达或次日达。实际

中药攻占全球,80个国家动起来了

“太激动人心了!中药攻占全球市场,我们有希望!”出席 “世界中医药服务贸易联合会”成立大会的一位代表发出了内心的感慨。日前,中国医药物资协会在加勒比海洋量子号游轮上主办的第十二届中国成长型医药企业发论坛暨世界中医药服务贸易推进大会上,5000名医药人士出席。在这次活动上,自全球80多个国家和地区的中医药行业代表共同发起成立了世界中医药服务贸易联合会。在中国倡导的“一带一路”获世界瞩目背景下,中药通

187家A股医药上市公司2017Q3营业收入及净利润

同仁堂 97.83 9.97% 8.19 8.07% 国药一致

2017中国更具竞争力医药上市公司榜单出炉

深度研究近一年,连续八年发布,2017中国最具竞争力医药上市公司20强榜单如约出炉。大势之下,谁是大势的宠儿,谁将成为退潮后的裸泳者?